4
Changes in Ownership
Sionna Therapeutics, Inc. Filed Acc 0002061851-25-000003
Chief Legal Officer sold 10,250 shares at $40.52 ($415,330)
- Chief Legal Officer acquired 10,250 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Fitzpatrick Jennifer · Chief Legal Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-05 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,250 | $6.11 | $62,628 | 10,250 | D |
| 2025-12-05 | Sale : show line 2 in the form 10b5-1 | −10,250 | $40.52 | $415,330 | 0 | D |
| Open-market sales · 10,250 sh · avg $40.52 · $415,330 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-05 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −10,250 | 61,185 | D |
Loading xslF345X05/edgardoc.xml…